While Organovo has been involved with multiple bioprinting breakthroughs and is involved in development of numerous products, their first product, exVive 3D Human Liver Tissue, will be the center of all points during their involvement at the Society of Toxicology’s (SOT) 55th Annual Meeting and ToxExpo, from March 13–17 in New Orleans. There will be an exhibitor-hosted session, as well as five other presentations, with topics such as ‘Functional Evaluation of Bioprinted Human Liver Organoid as a Liver’ and ‘Monocrotaline Toxicity in 3D Bioprinted Human Liver Tissue.’ We’ll be reporting back next week further as to the content of the presentations as they are going on. Read more at 3DPrint.com: http://3dprint.com/123639/exvive-3d-human-liver-tissue/